Analyst Ratings for Ironwood Pharmaceuticals (IRWD)
IRWD Rating Summary
IRWD Price Target Summary
- Highest: $24.00 (Credit Suisse)
- Lowest: $8.00 (Cantor Fitzgerald)
- Average: $15.30
Overall Rating:
NEUTRAL
Rating Trend:
=
Avg. $ Target:
$15.30 (+20%)
| Date | Firm | Type | Rating (Past) |
PT (Past) |
Start $ | End $ | % Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 5/6/2013 | Cowen | Downgrade | Neutral (Outperform) |
N/A (N/A) |
14.61 | 12.75 | -12.73% | Details |
| 4/24/2013 | Wedbush | Downgrade | Underperform (Neutral) |
12.00 (13.00) |
16.77 | 12.75 | -23.97% | Details |
| 4/24/2013 | Morgan Stanley | Downgrade | Equalweight (Overweight) |
N/A (N/A) |
16.77 | 12.75 | -23.97% | Details |
| 3/15/2013 | Credit Suisse | Upgrade | Outperform (Neutral) |
24.00 (15.00) |
17.68 | 12.75 | -27.88% | Details |
| 1/31/2013 | Janney Montgomery Scott | New Coverage | Neutral (N/A) |
14.00 (N/A) |
12.91 | 12.75 | -1.24% | Details |
| 1/16/2013 | UBS | Downgrade | Sell (Neutral) |
N/A (N/A) |
14.69 | 12.75 | -13.21% | Details |
| 12/18/2012 | WallachBeth Capital | New Coverage | Hold (N/A) |
10.00 (N/A) |
10.96 | 12.75 | 16.33% | Details |
| 11/9/2012 | Mizuho Securities | New Coverage | Outperform (N/A) |
22.00 (N/A) |
11.68 | 12.75 | 9.16% | Details |
| 6/12/2012 | Aegis Capital | New Coverage | Buy (N/A) |
17.00 (N/A) |
12.41 | 12.75 | 2.74% | Details |
| 5/15/2012 | Jefferies | New Coverage | Hold (N/A) |
13.00 (N/A) |
13.20 | 12.75 | -3.41% | Details |
| 2/29/2012 | Cantor Fitzgerald » Updated 8/31/2012 |
Downgrade | Sell (N/A) |
8.00 (N/A) |
14.31 | 12.75 | -10.9% | Details |
| 1/6/2012 | ThinkEquity | New Coverage | Hold (N/A) |
13.00 (N/A) |
11.98 | 12.75 | 6.43% | Details |
| 8/26/2011 | Morgan Joseph | New Coverage | Buy (N/A) |
20.00 (N/A) |
12.26 | 12.75 | 4% | Details |
| 5/26/2011 | Duncan Williams | New Coverage | Hold (N/A) |
N/A (N/A) |
15.01 | 12.75 | -15.06% | Details |
| 5/5/2011 | Caris & Co. | New Coverage | Buy (N/A) |
N/A (N/A) |
14.10 | 12.75 | -9.57% | Details |
